loadpatents
name:-0.08225679397583
name:-0.052555084228516
name:-0.013681888580322
FOLTZ; Ian Patent Filings

FOLTZ; Ian

Patent Applications and Registrations

Patent applications and USPTO patent grants for FOLTZ; Ian.The latest application filed is for "st2 antigen binding proteins".

Company Profile
13.65.70
  • FOLTZ; Ian - Burnaby CA
  • Foltz; Ian - British Columbia CA
  • Foltz; Ian - Thousand Oaks CA
  • Foltz; Ian - Vancouver CA
  • Foltz, Ian - Bwnaby CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
St2 Antigen Binding Proteins
App 20220119537 - SMITH; Dirk E. ;   et al.
2022-04-21
Anti-human TREM2 antibodies and uses thereof
Grant 11,186,636 - Foltz , et al. November 30, 2
2021-11-30
ST2 antigen binding proteins
Grant 11,059,895 - Smith , et al. July 13, 2
2021-07-13
TREM2 Antigen Binding Proteins And Uses Thereof
App 20210054069 - Foltz; Ian ;   et al.
2021-02-25
Targeted Binding Agents Against B7-h1
App 20210017282 - QUEVA; CHRISTOPHE ;   et al.
2021-01-21
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof
App 20200062860 - Weber; Richard F. ;   et al.
2020-02-27
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
Grant 10,508,153 - Weber , et al. Dec
2019-12-17
St2 Antigen Binding Proteins
App 20190359720 - SMITH; Dirk E. ;   et al.
2019-11-28
Anti-PD-1 Antibodies and Methods of Treatment
App 20190270817 - Ali; Khaled M.K.Z. ;   et al.
2019-09-05
Antibodies To M-csf
App 20190202905 - Bedian; Vahe ;   et al.
2019-07-04
Antibodies to M-CSF
Grant 10,280,219 - Bedian , et al.
2019-05-07
ST2 antigen binding proteins
Grant 10,227,414 - Smith , et al.
2019-03-12
Interleukin-21 Muteins and Methods of Treatment
App 20190046611 - Ali; Khaled M.K.Z. ;   et al.
2019-02-14
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
Grant 10,118,968 - Weber , et al. November 6, 2
2018-11-06
ST2 antigen binding proteins
Grant 9,982,054 - Smith , et al. May 29, 2
2018-05-29
Alpha-4-beta-7 Heterodimer Specific Antagonist Antibody
App 20170275365 - Hsu; Hailing ;   et al.
2017-09-28
Antibodies To M-csf
App 20170275354 - Bedian; Vahe ;   et al.
2017-09-28
St2 Antigen Binding Proteins
App 20170267769 - SMITH; Dirk E. ;   et al.
2017-09-21
Antibodies Against T Cell Immunoglobulin Domain and Mucin Domain 1 (TIM-1) Antigen and Uses Thereof
App 20170218067 - Landes; Gregory M. ;   et al.
2017-08-03
Antibodies to M-CSF
Grant 9,718,883 - Bedian , et al. August 1, 2
2017-08-01
Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
Grant 9,580,503 - Landes , et al. February 28, 2
2017-02-28
Human antigen binding proteins that bind to a complex comprising .beta.-Klotho and an FGF receptor
Grant 9,574,002 - Li , et al. February 21, 2
2017-02-21
Gitr Antigen Binding Proteins
App 20170022285 - BEERS; Courtney ;   et al.
2017-01-26
St2 Antigen Binding Proteins
App 20170002079 - SMITH; Dirk E. ;   et al.
2017-01-05
Human FGF receptor and .beta.-Klotho binding proteins
Grant 9,517,264 - Fachini , et al. December 13, 2
2016-12-13
Methods of using an alpha-4-beta-7 heterodimer specific antagonist antibody
Grant 9,499,620 - Hsu , et al. November 22, 2
2016-11-22
GITR antigen binding proteins and methods of use thereof
Grant 9,464,139 - Beers , et al. October 11, 2
2016-10-11
Antibodies To M-csf
App 20160244519 - Bedian; Vahe ;   et al.
2016-08-25
ST2 antigen binding proteins
Grant 9,382,318 - Smith , et al. July 5, 2
2016-07-05
Anti-hepcidin antibodies and methods of use
Grant 9,315,577 - Foltz , et al. April 19, 2
2016-04-19
Human antigen binding proteins that bind .beta.-Klotho, FGF receptors and complexes thereof
Grant 9,284,378 - Hu , et al. March 15, 2
2016-03-15
Nucleic acid molecule encoding target antibodies directed to DLL4
Grant 9,206,255 - Foltz , et al. December 8, 2
2015-12-08
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof
App 20150315288 - Weber; Richard F. ;   et al.
2015-11-05
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
Grant 9,096,672 - Weber , et al. August 4, 2
2015-08-04
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
Grant 9,085,624 - Weber , et al. July 21, 2
2015-07-21
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
Grant 9,073,998 - Weber , et al. July 7, 2
2015-07-07
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
Grant 9,062,113 - Weber , et al. June 23, 2
2015-06-23
Antibodies Directed To Alpha V Beta 6 And Uses Thereof
App 20150166663 - RINKENBERGER; JULIE ;   et al.
2015-06-18
Alpha-4-beta-7 Heterodimer Specific Antagonist Antibody
App 20150086563 - Hsu; Hailing ;   et al.
2015-03-26
Gitr Antigen Binding Proteins
App 20150064204 - BEERS; Courtney ;   et al.
2015-03-05
Antibodies directed to .alpha.V.beta.6 and uses thereof
Grant 8,894,998 - Rinkenberger , et al. November 25, 2
2014-11-25
Alpha-4-beta-7 heterodimer specific antagonist antibody
Grant 8,871,490 - Hsu , et al. October 28, 2
2014-10-28
Anti-cxcr4 Antibodies And Methods Of Use
App 20140314784 - Bedian; Vahe ;   et al.
2014-10-23
Antibodies directed to ERBB2
Grant 8,858,942 - Cartlidge , et al. October 14, 2
2014-10-14
Targeted Binding Agents Directed To Dll4 And Uses Thereof
App 20140206853 - Foltz; Ian ;   et al.
2014-07-24
Targeted binding agents directed to PDGRF-alpha and uses thereof
Grant 8,697,664 - Laing , et al. April 15, 2
2014-04-15
Method of treating a malignant tumor by administering antibodies directed to DLL4
Grant 8,663,636 - Foltz , et al. March 4, 2
2014-03-04
St2 Antigen Binding Proteins
App 20140004107 - SMITH; Dirk E. ;   et al.
2014-01-02
Alpha-4-beta-7 Heterodimer Specific Antagonist Antibody
App 20130302354 - HSU; HAILING ;   et al.
2013-11-14
Antibodies Directed To Alpha V Beta 6 And Uses Thereof
App 20130202621 - Rinkenberger; Julie ;   et al.
2013-08-08
Alpha-4-beta-7 heterodimer specific antagonist antibody
Grant 8,454,962 - Hsu , et al. June 4, 2
2013-06-04
Alpha-4-beta-7 heterodimer specific antagonist antibody
Grant 8,454,961 - Hsu , et al. June 4, 2
2013-06-04
Human Fgf Receptor And Beta-klotho Binding Proteins
App 20130129725 - Fachin ; Roger ;   et al.
2013-05-23
Alpha-4 beta-7 heterodimer specific antagonist antibody
Grant 8,444,981 - Hsu , et al. May 21, 2
2013-05-21
Polypeptides And Antibodies
App 20130101589 - Gliniak; Brian ;   et al.
2013-04-25
Antibodies Directed to ERBB2
App 20130089544 - Cartilage; Susan Ann ;   et al.
2013-04-11
Antibodies directed to .alpha.V.beta.6 and uses thereof
Grant 8,398,975 - Rinkenberger , et al. March 19, 2
2013-03-19
Antibodies to ErbB2
Grant 8,350,011 - Cartlidge , et al. January 8, 2
2013-01-08
Human Antigen Binding Proteins That Bind To A Complex Comprising Beta-klotho And An Fgf Receptor
App 20120328616 - LI; YANG ;   et al.
2012-12-27
Antibodies Against T Cell Immunoglobulin Domain And Mucin Domain 1 (tim-1) Antigen And Uses Thereof
App 20120251555 - Landes; Gregory M. ;   et al.
2012-10-04
Antibodies To M-csf
App 20120244167 - Bedian; Vahe ;   et al.
2012-09-27
Targeted Binding Agents Directed To Dll4 And Uses Thereof 524
App 20120195905 - Bedian; Vahe ;   et al.
2012-08-02
Alpha-4-beta-7 Heterodimer Specific Antagonist Antibody
App 20120183561 - HSU; Hailing ;   et al.
2012-07-19
Alpha-4-beta-7 Heterodimer Specific Antagonist Antibody
App 20120177662 - HSU; Hailing ;   et al.
2012-07-12
Targeted antibodies directed to DLL4
Grant 8,192,738 - Bedian , et al. June 5, 2
2012-06-05
Nucleic acid molecules encoding antibodies to M-CSF
Grant 8,188,249 - Bedian , et al. May 29, 2
2012-05-29
TARGETED BINDING AGENTS DIRECTED TO a5BETA1 AND USES THEREOF
App 20120114667 - Eberlein; Catherine Anne ;   et al.
2012-05-10
TARGETED BINDING AGENTS DIRECTED TO a5 1 AND USES THEREOF
App 20120107324 - Eberlein; Catherine Anne ;   et al.
2012-05-03
Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
Grant 8,067,544 - Landes , et al. November 29, 2
2011-11-29
Fully human monoclonal antibodies to IL-13
Grant 7,994,302 - Foltz , et al. August 9, 2
2011-08-09
Anti-hepcidin Antibodies And Methods Of Use
App 20110150888 - Foltz; Ian ;   et al.
2011-06-23
Human Antigen Binding Proteins That Bind Beta-klotho, Fgf Receptors And Complexes Thereof
App 20110135657 - Hu; Shaw-Fen Sylvia ;   et al.
2011-06-09
Targeted Binding Agents Directed To Pdgrf-alpha And Uses Thereof
App 20110020360 - LAING; NAOMI ;   et al.
2011-01-27
Antibodies Directed to Alpha V Beta 6 And Uses Thereof
App 20100330103 - RINKENBERGER; Julie ;   et al.
2010-12-30
Alpha-4 Beta-7 Heterodimer Specific
App 20100254975 - Hsu; Hailing ;   et al.
2010-10-07
Antibodies To M-csf
App 20100247545 - Bedian; Vahe ;   et al.
2010-09-30
Targeted Binding Agents Directed To Dll4 And Uses Thereof 524
App 20100196385 - Bedian; Vahe ;   et al.
2010-08-05
Targeted binding agents directed to PDGFR-alpha and uses thereof
Grant 7,754,859 - Laing , et al. July 13, 2
2010-07-13
Antibodies To Erbb2
App 20100158926 - Cartilage; Sue ;   et al.
2010-06-24
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
Grant 7,736,644 - Weber , et al. June 15, 2
2010-06-15
Methods of treating arthritic conditions with antibodies to M-CSF
Grant 7,728,113 - Bedian , et al. June 1, 2
2010-06-01
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof
App 20100111979 - WEBER; RICHARD ;   et al.
2010-05-06
Fully Human Monoclonal Antibodies To Il-13
App 20100047253 - Foltz; Ian ;   et al.
2010-02-25
Targeted Binding Agents Directed To Pdgfr-alpha And Uses Thereof
App 20090324601 - Blakey; David Charles ;   et al.
2009-12-31
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
Grant 7,628,986 - Weber , et al. December 8, 2
2009-12-08
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof
App 20090240038 - Weber; Richard ;   et al.
2009-09-24
Antibodies to M-CSF
Grant 7,592,430 - Bedian , et al. September 22, 2
2009-09-22
Polypeptides and Antibodies
App 20090226438 - Gliniak; Brian ;   et al.
2009-09-10
Fully human monoclonal antibodies to IL-13
Grant 7,585,500 - Foltz , et al. September 8, 2
2009-09-08
Binding proteins specific for human matriptase
Grant 7,572,444 - Foltz , et al. August 11, 2
2009-08-11
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof
App 20090175887 - Weber; Richard ;   et al.
2009-07-09
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof
App 20090155282 - Weber; Richard ;   et al.
2009-06-18
Antibodies Directed To The Deletion Mutants Of Epidermal Growth Factor Receptor And Uses Thereof
App 20090156790 - Weber; Richard ;   et al.
2009-06-18
TRAIL receptor-2 polypeptides and antibodies
Grant 7,521,048 - Gliniak , et al. April 21, 2
2009-04-21
Antibodies to M-CSF
App 20080254032 - Bedian; Vahe ;   et al.
2008-10-16
Antibodies against carbonic anhydrase IX (CA IX) tumor antigen
Grant 7,378,091 - Gudas , et al. May 27, 2
2008-05-27
Targeted Binding Agents Directed To Pdgfr-alpha And Uses Thereof
App 20080089837 - LAING; Naomi ;   et al.
2008-04-17
Antibodies Directed to AlphaVBeta6 and Uses Thereof
App 20080057063 - Rinkenberger; Julie ;   et al.
2008-03-06
Antibodies to M-CSF
Grant 7,326,414 - Bedian , et al. February 5, 2
2008-02-05
Methods of use for antibodies against parathyroid hormone
Grant 7,318,925 - Roskos , et al. January 15, 2
2008-01-15
Antibodies directed to parathyroid hormone (PTH) and uses thereof
Grant 7,288,253 - Roskos , et al. October 30, 2
2007-10-30
Anti-CD45RB antibodies
Grant 7,265,212 - Babcook , et al. September 4, 2
2007-09-04
Polypeptides and antibodies
App 20070179086 - Gliniak; Brian ;   et al.
2007-08-02
Binding proteins specific for human matriptase
App 20060171884 - Foltz; Ian ;   et al.
2006-08-03
Antibodies to M-CSF
App 20060153850 - Bedian; Vahe ;   et al.
2006-07-13
Fully human monoclonal antibodies to IL-13
App 20060140948 - Foltz; Ian ;   et al.
2006-06-29
Antibodies against parathyroid hormone
App 20060062783 - Roskos; Lorin ;   et al.
2006-03-23
Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
App 20050084449 - Landes, Gregory M. ;   et al.
2005-04-21
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
App 20050059087 - Weber, Richard ;   et al.
2005-03-17
Antibodies to M-CSF
App 20050059113 - Bedian, Vahe ;   et al.
2005-03-17
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
App 20050053608 - Weber, Richard ;   et al.
2005-03-10
Antibodies directed to parathyroid hormone (PTH) and uses thereof
App 20050031614 - Roskos, Lorin ;   et al.
2005-02-10
Antibodies against carbonic anydrase IX (CA IX) tumor antigen
App 20040018198 - Gudas, Jean ;   et al.
2004-01-29
Anti-CD45RB antibodies for use in treating autoimmune disease and transplant rejection
App 20030232009 - Babcook, John S. ;   et al.
2003-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed